Synthesis and evaluation of poly(styrene-co-maleic acid) micellar nanocarriers for the delivery of tanespimycin

International Journal of Pharmaceutics

Volumn 420, Issue 1, 2011, Pages 111-117

  Larson, Nate ^a   Greish, Khaled ^a,d   Bauer, Hillevi ^a   Maeda, Hiroshi ^c   Ghandehari, Hamidreza ^a,b  

^a UNIVERSITY OF UTAH   (United States)

^b University of Utah   (United States)

^c SOJO UNIVERSITY   (Japan)

^d UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

17 AAG; Polymeric micelle; Prostate cancer; Tanespimycin

Indexed keywords

BOVINE SERUM ALBUMIN; NANOCARRIER; STYRENE MALEIC ANHYDRIDE COPOLYMER; TANESPIMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER REGRESSION; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG POTENCY; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IN VIVO STUDY; LIGHT SCATTERING; MICELLE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROSTATE CANCER; SYNTHESIS; TUMOR XENOGRAFT; ZETA POTENTIAL;

ANIMALS; ANTINEOPLASTIC AGENTS; BENZOQUINONES; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMISTRY, PHARMACEUTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; DRUG COMPOUNDING; HUMANS; HYDROGEN-ION CONCENTRATION; INHIBITORY CONCENTRATION 50; INJECTIONS, SUBCUTANEOUS; KINETICS; LACTAMS, MACROCYCLIC; LIGHT; MALE; MALEATES; MICE; MICE, NUDE; MICELLES; NANOPARTICLES; NANOTECHNOLOGY; POLYSTYRENES; PROSTATIC NEOPLASMS; SCATTERING, RADIATION; SOLUBILITY; TECHNOLOGY, PHARMACEUTICAL; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 80054716147     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.08.011     Document Type: Article

References (37)

1. U. Banerji, A. O'donnell, M. Scurr, S. Pacey, S. Stapleton, Y. Asad, L. Simmons, A. Maloney, F. Raynaud, M. Campbell, M. Walton, S. Lakhani, S. Kaye, P. Workman, and I. Judson Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies J. Clin. Oncol. 23 2005 4152 4161 (Pubitemid 46211321)
2. E. Blanco, C.W. Kessinger, B.D. Sumer, and J. Gao Multifunctional micellar nanomedicine for cancer therapy Exp. Biol. Med. 234 2009 123 131
3. M.P. Borgman, O. Aras, S. Geyser-Stoops, E.A. Sausville, and H. Ghandehari Biodistribution of HPMA copolymer-aminohexylgeldanamycin-RGDfK conjugates for prostate cancer drug delivery Mol. Pharm. 6 2009 1836 1847
4. J. Buchner Hsp90 & Co. - a holding for folding Trends Biochem. Sci. 24 1999 136 141
5. A.M. Burger, H.H. Fiebig, S.F. Stinson, and E.A. Sausville 17-(Allylamino)-17-demethoxygeldanamycin activity in human melanoma models Anticancer Drugs 15 2004 377 387 (Pubitemid 38526763)
6. J. Claracq, S.F.C.R. Santos, J. Duhamel, C. Dumousseaux, and J.-M. Corpart Rigid interior of styrene-maleic anhydride copolymer aggregates probed by fluorescence spectroscopy Langmuir 18 2002 3829 3835 (Pubitemid 35383647)
7. S.R. Croy, and G.S. Kwon Polymeric micelles for drug delivery Curr. Pharm. Des. 12 2006 4669 4684 (Pubitemid 44835136)
8. J. Daruwalla, M. Nikfarjam, K. Greish, C. Malcontenti-Wilson, V. Muralidharan, C. Christophi, and H. Maeda In vitro and in vivo evaluation of tumor targeting styrene-maleic acid copolymer-pirarubicin micelles: survival improvement and inhibition of liver metastases Cancer Sci. 101 2010 1866 1874
9. Y. Fukuyo, C.R. Hunt, and N. Horikoshi Geldanamycin and its anti-cancer activities Cancer Lett. 290 2010 24 35
10. G. Gaucher, M.H. Dufresne, V.P. Sant, N. Kang, D. Maysinger, and J.C. Leroux Block copolymer micelles: preparation, characterization and application in drug delivery J. Control. Release 109 2005 169 188 (Pubitemid 41742123)
11. J. Ge, E. Normant, J.R. Porter, J.A. Ali, M.S. Dembski, Y. Gao, A.T. Georges, L. Grenier, R.H. Pak, J. Patterson, J.R. Sydor, T.T. Tibbitts, J.K. Tong, J. Adams, and V.J. Palombella Design, synthesis, and biological evaluation of hydroquinone derivatives of 17-amino-17-demethoxygeldanamycin as potent, water-soluble inhibitors of Hsp90 J. Med. Chem. 49 2006 4606 4615 (Pubitemid 44162687)
12. H. Gelderblom, J. Verweij, K. Nooter, and A. Sparreboom Cremophor® EL: the drawbacks and advantages of vehicle selection for drug formulation Eur. J. Cancer 37 2001 1590 1598 (Pubitemid 32778603)
13. K. Greish Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines J. Drug Target 15 2007 457 464 (Pubitemid 47209047)
14. K. Greish, J. Fang, T. Inutsuka, A. Nagamitsu, and H. Maeda Macromolecular therapeutics: advantages and prospects with special emphasis on solid tumour targeting Clin. Pharmacokinet. 42 2003 1089 1105 (Pubitemid 37357647)
15. K. Greish, T. Sawa, J. Fang, T. Akaike, and H. Maeda SMA-doxorubicin, a new polymeric micellar drug for effective targeting to solid tumours J. Control. Release 97 2004 219 230 (Pubitemid 38759479)
16. L. Gros, H. Ringsdorf, and H. Schupp Polymeric antitumor agents on a molecular and on a cellular level? Angew. Chem. Int. Ed. Engl. 20 1981 305 325 (Pubitemid 11416959)
17. A.K. Iyer, K. Greish, J. Fang, R. Murakami, and H. Maeda High-loading nanosized micelles of copoly(styrene-maleic acid)-zinc protoporphyrin for targeted delivery of a potent heme oxygenase inhibitor Biomaterials 28 2007 1871 1881 (Pubitemid 46123550)
18. Y. Kasuya, Z.R. Lu, P. Kopeckova, S.E. Tabibi, and J. Kopecek Influence of the structure of drug moieties on the in vitro efficacy of HPMA copolymer-geldanamycin derivative conjugates Pharm. Res. 19 2002 115 123 (Pubitemid 34168208)
19. L.R. Kelland, S.Y. Sharp, P.M. Rogers, T.G. Myers, and P. Workman DT-diaphorase expression and tumor cell sensitivity to 17-allylamino, 17-demethoxygeldanamycin, an inhibitor of heat shock protein 90 J. Natl. Cancer Inst. 91 1999 1940 1949
20. A. Kobayashi, T. Oda, and H. Maeda Protein binding of macromolecular anticancer agent SMANCS: characterization of poly(styrene-co-maleic acid) derivatives as an albumin binding ligand J. Bioact. Compat. Polym. 3 1988 319 333 (Pubitemid 19059729)
21. N. Larson, A. Ray, A. Malugin, D.B. Pike, and H. Ghandehari HPMA copolymer-aminohexylgeldanamycin conjugates targeting cell surface expressed GRP78 in prostate cancer Pharm. Res. 27 2010 2683 2693
22. H. Maeda SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy Adv. Drug Deliv. Rev. 46 2001 169 185
23. Y. Matsumura, T. Oda, and H. Maeda General mechanism of intratumor accumulation of macromolecules: advantage of macromolecular therapeutics Gan To Kagaku Ryoho 14 1987 821 829 (Pubitemid 17041105)
24. K. Park Nanotechnology: what it can do for drug delivery J. Control. Release 120 2007 1 3 (Pubitemid 46874626)
25. J.R. Porter, J. Ge, J. Lee, E. Normant, and K. West Ansamycin inhibitors of Hsp90: nature's prototype for anti-chaperone therapy Curr. Top. Med. Chem. 9 2009 1386 1418
26. V.B. Rodriguez, S.M. Henry, A.S. Hoffman, P.S. Stayton, X. Li, and S.H. Pun Encapsulation and stabilization of indocyanine green within poly(styrene-alt-maleic anhydride) block-poly(styrene) micelles for near-infrared imaging J. Biomed. Opt. 13 2008 014025
27. E.K. Rowinsky, and R.C. Donehower Paclitaxel (taxol) N. Engl. J. Med. 332 1995 1004 1014
28. E.A. Sausville, J.E. Tomaszewski, and P. Ivy Clinical development of 17-allylamino, 17-demethoxygeldanamycin Curr. Cancer Drug Targets 3 2003 377 383 (Pubitemid 37128324)
29. S. Sharp, and P. Workman Inhibitors of the HSP90 molecular chaperone: current status Adv. Cancer Res. 95 2006 323 348 (Pubitemid 44088424)
30. H.-C. Shin, A.W.G. Alani, D.A. Rao, N.C. Rockich, and G.S. Kwon Multi-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugs J. Control. Release 140 2009 294 300
31. V. Subr, J. Kopecek, J. Pohl, M. Baudys, and V. Kostka Cleavage of oligopeptide side-chains in N-(2-hydroxypropyl)methacrylamide copolymers by mixtures of lysosomal enzymes J. Control. Release 8 1988 133 140 (Pubitemid 19010920)
32. J.G. Supko, R.L. Hickman, M.R. Grever, and L. Malspeis Preclinical pharmacologic evaulation of geldanamycin as an antitumor agent Cancer Chemother. Pharmacol. 36 1994 305 315
33. F. Suzuki, T. Munakata, and H. Maeda Interferon induction by SMANCS: a polymer-conjugated derivative of neocarzinostatin Anticancer Res. 8 1988 97 103
34. F. Suzuki, R.B. Pollard, S. Uchimura, T. Munakata, and H. Maeda Role of natural killer cells and macrophages in the nonspecific resistance to tumors in mice stimulated with SMANCS, a polymer-conjugated derivative of neocarzinostatin Cancer Res. 50 1990 3897 3904 (Pubitemid 20225603)
35. L. Whitesell, and S.L. Lindquist HSP90 and the chaperoning of cancer Nat. Rev. Cancer 5 2005 761 772 (Pubitemid 41400776)
36. M.P. Xiong, J.A. Yáñez, G.S. Kwon, N.M. Davies, and M.L. Forrest A cremophor-free formulation for tanespimycin (17-AAG) using PEO-b-PDLLA micelles: characterization and pharmacokinetics in rats J. Pharm. Sci. 98 2009 1577 1586
37. Zhong, Z., Licari, P.J., 2005. Pharmaceutical solution formulations containing 17-AAG. US Patent Application, 20,050,256,097.